speb/financial-data huggingface dataset:
GME.DE cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: 0.00
GME.DE cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 0.00
GME.DE income_statement (annual, 2025-12-31) — Net Income: -818985.14
GME.DE income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -818985.14
GME.DE income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -816875.89
GME.DE income_statement (annual, 2025-12-31) — Net Income Extraordinary: -11516.73
GME.DE income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -807468.41
GME.DE income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -807468.41
GME.DE cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -828000.00
GME.DE income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -828392.62
GME.DE cash_flow (annual, 2025-12-31) — Net Intangibles Purchase And Sale: -430000.00
GME.DE income_statement (annual, 2025-12-31) — Net Interest Income: 52642.31
GME.DE cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: 264000.00
GME.DE cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: -770000.00
GME.DE cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: -770000.00
GME.DE income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: 52642.31
GME.DE balance_sheet (annual, 2025-12-31) — Net PPE: 6984570.00
GME.DE balance_sheet (quarterly, 2025-12-31) — Net PPE: 6984570.00
GME.DE cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -162000.00
GME.DE balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 17925582.10
GME.DE balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 17925582.10
GME.DE balance_sheet (annual, 2025-12-31) — Non Current Deferred Revenue: 791209.99
GME.DE balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Revenue: 791209.99
GME.DE balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 123608.41
GME.DE balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 123608.41
GME.DE income_statement (annual, 2025-12-31) — Normalized EBITDA: 1371452.34
GME.DE income_statement (annual, 2025-12-31) — Normalized Income: 132278.84
GME.DE cash_flow (annual, 2025-12-31) — Operating Cash Flow: 1304000.00
GME.DE income_statement (annual, 2025-12-31) — Operating Income: -60251.22
GME.DE income_statement (annual, 2025-12-31) — Operating Revenue: 16030364.98
GME.DE balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 5411945.00
GME.DE balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 5411945.00
GME.DE balance_sheet (annual, 2025-12-31) — Other Current Assets: 2237650.04
GME.DE balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 2237650.04
GME.DE balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 272863.00
GME.DE balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 272863.00
GME.DE balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 1730764.20
GME.DE balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 1730764.20
GME.DE cash_flow (annual, 2025-12-31) — Other Non Cash Items: -123000.00
GME.DE balance_sheet (annual, 2025-12-31) — Other Non Current Assets: -0.52
GME.DE balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: -0.52
GME.DE balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 450418.08
GME.DE balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 450418.08
GME.DE income_statement (annual, 2025-12-31) — Other Operating Expenses: 102366.80
GME.DE balance_sheet (annual, 2025-12-31) — Other Receivables: 153109.70
GME.DE balance_sheet (quarterly, 2025-12-31) — Other Receivables: 153109.70
GME.DE balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 1656863.14
GME.DE balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 1656863.14
GME.DE income_statement (annual, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
GME.DE balance_sheet (annual, 2025-12-31) — Payables: 1379794.30
GME.DE balance_sheet (quarterly, 2025-12-31) — Payables: 1379794.30
GME.DE balance_sheet (annual, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 457178.00
GME.DE balance_sheet (quarterly, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 457178.00
GME.DE balance_sheet (annual, 2025-12-31) — Prepaid Assets: -1469027.49
GME.DE balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: -1469027.49
GME.DE income_statement (annual, 2025-12-31) — Pretax Income: -895452.66
GME.DE balance_sheet (annual, 2025-12-31) — Properties: 0.00
GME.DE balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
GME.DE cash_flow (annual, 2025-12-31) — Purchase Of Intangibles: -430000.00
GME.DE cash_flow (annual, 2025-12-31) — Purchase Of Investment: -16000.00
GME.DE cash_flow (annual, 2025-12-31) — Purchase Of PPE: -162000.00
GME.DE balance_sheet (annual, 2025-12-31) — Raw Materials: 2179901.05
GME.DE balance_sheet (quarterly, 2025-12-31) — Raw Materials: 2179901.05
GME.DE income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 5499093.08
GME.DE income_statement (annual, 2025-12-31) — Reconciled Depreciation: 1159000.00
GME.DE cash_flow (annual, 2025-12-31) — Repayment Of Debt: -770000.00
GME.DE cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: 0.00
GME.DE balance_sheet (annual, 2025-12-31) — Retained Earnings: -1562108.75
GME.DE balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -1562108.75
GME.DE cash_flow (annual, 2025-12-31) — Sale Of Business: 0.00
GME.DE cash_flow (annual, 2025-12-31) — Sale Of Investment: 280000.00
GME.DE income_statement (annual, 2025-12-31) — Selling And Marketing Expense: 995000.00
GME.DE income_statement (annual, 2025-12-31) — Selling General And Administration: 3607000.00
GME.DE balance_sheet (annual, 2025-12-31) — Share Issued: 5444998.00
GME.DE balance_sheet (quarterly, 2025-12-31) — Share Issued: 5444998.00
GME.DE income_statement (annual, 2025-12-31) — Special Income Charges: -1059468.47
GME.DE balance_sheet (annual, 2025-12-31) — Stockholders Equity: 19656346.30
GME.DE balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 19656346.30
GME.DE balance_sheet (annual, 2025-12-31) — Tangible Book Value: 17925582.10
GME.DE balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 17925582.10
GME.DE income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: -90395.99
GME.DE income_statement (annual, 2025-12-31) — Tax Provision: -78576.77
GME.DE income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.09
GME.DE cash_flow (annual, 2025-12-31) — Taxes Refund Paid: -439000.00
GME.DE balance_sheet (annual, 2025-12-31) — Total Assets: 25995145.47
GME.DE balance_sheet (quarterly, 2025-12-31) — Total Assets: 25995145.47
GME.DE balance_sheet (annual, 2025-12-31) — Total Capitalization: 20511346.30
GME.DE balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 20511346.30
GME.DE balance_sheet (annual, 2025-12-31) — Total Debt: 2476000.00
GME.DE balance_sheet (quarterly, 2025-12-31) — Total Debt: 2476000.00
GME.DE balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 19448435.02
GME.DE balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 19448435.02
GME.DE income_statement (annual, 2025-12-31) — Total Expenses: 16090616.20
GME.DE balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 6546710.45
GME.DE balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 6546710.45
GME.DE balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 9441333.68
GME.DE balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 9441333.68
GME.DE balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 2813178.75
GME.DE balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 2813178.75
GME.DE balance_sheet (annual, 2025-12-31) — Total Tax Payable: 713959.00
GME.DE balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 713959.00
GME.DE income_statement (annual, 2025-12-31) — Total Unusual Items: -1030143.24
GME.DE income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -1030143.24
GME.DE balance_sheet (annual, 2025-12-31) — Treasury Shares Number: 33053.00
GME.DE balance_sheet (quarterly, 2025-12-31) — Treasury Shares Number: 33053.00
GME.DE balance_sheet (annual, 2025-12-31) — Work In Process: 1013859.70
GME.DE balance_sheet (quarterly, 2025-12-31) — Work In Process: 1013859.70
GME.DE balance_sheet (annual, 2025-12-31) — Working Capital: 12820280.09
GME.DE balance_sheet (quarterly, 2025-12-31) — Working Capital: 12820280.09
GME.DE income_statement (annual, 2025-12-31) — Write Off: 1059468.47
GMED cash_flow (annual, 2021-12-31) — Amortization Of Securities: 2781000.00
GMED cash_flow (annual, 2021-12-31) — Asset Impairment Charge: 6143000.00
GMED cash_flow (annual, 2021-12-31) — Common Stock Issuance: 63496000.00
GMED cash_flow (annual, 2021-12-31) — Issuance Of Capital Stock: 63496000.00
GMED balance_sheet (annual, 2021-12-31) — Other Payable: 2200000.00
GMED income_statement (annual, 2021-12-31) — Other Special Charges: 5921000.00
GMED balance_sheet (annual, 2021-12-31) — Prepaid Assets: 18417000.00
GMED income_statement (annual, 2022-12-31) — +Operating Expense: 522867000.00
GMED income_statement (annual, 2022-12-31) — +Total Revenue: 1022843000.00
GMED balance_sheet (annual, 2022-12-31) — Accounts Payable: 36101000.00
GMED balance_sheet (annual, 2022-12-31) — Accounts Receivable: 213247000.00
GMED balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -343036000.00
GMED balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 630952000.00
GMED balance_sheet (annual, 2022-12-31) — Allowance For Doubtful Accounts Receivable: -4724000.00
GMED income_statement (annual, 2022-12-31) — Amortization: 17735000.00
GMED income_statement (annual, 2022-12-31) — Amortization Of Intangibles Income Statement: 17735000.00
GMED cash_flow (annual, 2022-12-31) — Amortization Of Securities: 5389000.00
GMED cash_flow (annual, 2022-12-31) — Asset Impairment Charge: 6400000.00
GMED income_statement (annual, 2022-12-31) — Basic Average Shares: 100469000.00
GMED income_statement (annual, 2022-12-31) — Basic EPS: 1.89
GMED cash_flow (annual, 2022-12-31) — Beginning Cash Position: 193069000.00
GMED balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 51510000.00
GMED cash_flow (annual, 2022-12-31) — Capital Expenditure: -74047000.00
GMED balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 6011000.00
GMED balance_sheet (annual, 2022-12-31) — Capital Stock: 100000.00
GMED balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 150466000.00
GMED balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 446058000.00
GMED cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: -109962000.00
GMED cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -110362000.00
GMED cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 178468000.00
GMED cash_flow (annual, 2022-12-31) — Change In Account Payable: 14418000.00
GMED cash_flow (annual, 2022-12-31) — Change In Accrued Expense: 6087000.00
GMED cash_flow (annual, 2022-12-31) — Change In Inventory: -61745000.00
GMED cash_flow (annual, 2022-12-31) — Change In Other Working Capital: -2887000.00
GMED cash_flow (annual, 2022-12-31) — Change In Payable: 14418000.00
GMED cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 20505000.00
GMED cash_flow (annual, 2022-12-31) — Change In Prepaid Assets: -10292000.00
GMED cash_flow (annual, 2022-12-31) — Change In Receivables: -50843000.00
GMED cash_flow (annual, 2022-12-31) — Change In Working Capital: -105262000.00
GMED cash_flow (annual, 2022-12-31) — Changes In Account Receivables: -50843000.00
GMED cash_flow (annual, 2022-12-31) — Changes In Cash: -41856000.00
GMED balance_sheet (annual, 2022-12-31) — Common Stock: 100000.00
GMED balance_sheet (annual, 2022-12-31) — Common Stock Equity: 1846373000.00
GMED cash_flow (annual, 2022-12-31) — Common Stock Payments: -144493000.00
GMED income_statement (annual, 2022-12-31) — Cost Of Revenue: 263725000.00
GMED balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 28788000.00
GMED balance_sheet (annual, 2022-12-31) — Current Assets: 983344000.00
GMED balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 2536000.00
GMED balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 2536000.00
GMED balance_sheet (annual, 2022-12-31) — Current Deferred Liabilities: 14100000.00
GMED balance_sheet (annual, 2022-12-31) — Current Deferred Revenue: 14100000.00
GMED balance_sheet (annual, 2022-12-31) — Current Liabilities: 159204000.00
GMED cash_flow (annual, 2022-12-31) — Deferred Income Tax: -22223000.00
GMED cash_flow (annual, 2022-12-31) — Deferred Tax: -22223000.00
GMED cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 68252000.00
GMED income_statement (annual, 2022-12-31) — Depreciation Amortization Depletion Income Statement: 17735000.00
GMED cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 68252000.00
GMED income_statement (annual, 2022-12-31) — Depreciation And Amortization In Income Statement: 17735000.00
GMED income_statement (annual, 2022-12-31) — Diluted Average Shares: 102643000.00
GMED income_statement (annual, 2022-12-31) — Diluted EPS: 1.85
GMED income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 190169000.00
GMED income_statement (annual, 2022-12-31) — EBIT: 236251000.00
GMED income_statement (annual, 2022-12-31) — EBITDA: 304503000.00
GMED cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: -747000.00
GMED cash_flow (annual, 2022-12-31) — End Cash Position: 150466000.00
GMED cash_flow (annual, 2022-12-31) — Financing Cash Flow: -109962000.00
GMED balance_sheet (annual, 2022-12-31) — Finished Goods: 219958000.00
GMED cash_flow (annual, 2022-12-31) — Free Cash Flow: 104421000.00
GMED income_statement (annual, 2022-12-31) — Gain On Sale Of Security: -1020000.00
GMED balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -24630000.00
GMED balance_sheet (annual, 2022-12-31) — Goodwill: 197471000.00
GMED balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 261045000.00
GMED balance_sheet (annual, 2022-12-31) — Gross Accounts Receivable: 217971000.00
GMED balance_sheet (annual, 2022-12-31) — Gross PPE: 592753000.00
GMED income_statement (annual, 2022-12-31) — Gross Profit: 759118000.00
GMED cash_flow (annual, 2022-12-31) — Income Tax Paid Supplemental Data: 77823000.00
GMED balance_sheet (annual, 2022-12-31) — Income Tax Payable: 990000.00
GMED balance_sheet (annual, 2022-12-31) — Inventory: 298981000.00
GMED balance_sheet (annual, 2022-12-31) — Invested Capital: 1846373000.00
GMED cash_flow (annual, 2022-12-31) — Investing Cash Flow: -110362000.00
GMED balance_sheet (annual, 2022-12-31) — Investmentin Financial Assets: 495852000.00
GMED balance_sheet (annual, 2022-12-31) — Investments And Advances: 495852000.00
GMED balance_sheet (annual, 2022-12-31) — Land And Improvements: 8277000.00
GMED balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 3475000.00
GMED balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 3475000.00
GMED cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: -31435000.00
GMED cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: -144493000.00
GMED cash_flow (annual, 2022-12-31) — Net Foreign Currency Exchange Gain Loss: 0.00
GMED income_statement (annual, 2022-12-31) — Net Income: 190169000.00
GMED income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 190169000.00
GMED income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 190169000.00
GMED income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 190169000.00
GMED income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 190169000.00
GMED cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 190169000.00
GMED income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 190169000.00
GMED income_statement (annual, 2022-12-31) — Net Interest Income: 14233000.00
GMED cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: -4880000.00
GMED income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: 14233000.00
GMED cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -7185000.00
GMED balance_sheet (annual, 2022-12-31) — Net PPE: 249717000.00
GMED cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -74047000.00
GMED balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 1585328000.00
GMED balance_sheet (annual, 2022-12-31) — Non Current Deferred Assets: 48845000.00
GMED balance_sheet (annual, 2022-12-31) — Non Current Deferred Liabilities: 1779000.00
GMED balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Assets: 48845000.00
GMED balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 1779000.00
GMED income_statement (annual, 2022-12-31) — Normalized EBITDA: 313823000.00
GMED income_statement (annual, 2022-12-31) — Normalized Income: 197466560.00
GMED cash_flow (annual, 2022-12-31) — Operating Cash Flow: 178468000.00
GMED cash_flow (annual, 2022-12-31) — Operating Gains Losses: 299000.00
GMED income_statement (annual, 2022-12-31) — Operating Income: 236251000.00
GMED income_statement (annual, 2022-12-31) — Operating Revenue: 1022843000.00
GMED balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 100192379.00
GMED balance_sheet (annual, 2022-12-31) — Other Current Assets: 20997000.00
GMED balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 13308000.00
GMED balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: -24630000.00
GMED income_statement (annual, 2022-12-31) — Other Income Expense: -7465000.00
GMED balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 63574000.00
GMED cash_flow (annual, 2022-12-31) — Other Non Cash Items: 2635000.00
GMED balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 37323000.00
GMED balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 65295000.00
GMED income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: 1855000.00
GMED balance_sheet (annual, 2022-12-31) — Other Properties: 532966000.00
GMED balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 295592000.00
GMED income_statement (annual, 2022-12-31) — Other Special Charges: 2341000.00
GMED balance_sheet (annual, 2022-12-31) — Payables: 47120000.00
GMED balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 75908000.00
GMED balance_sheet (annual, 2022-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 53352000.00
GMED income_statement (annual, 2022-12-31) — Pretax Income: 243019000.00
GMED cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 41716000.00
GMED balance_sheet (annual, 2022-12-31) — Properties: 0.00
GMED cash_flow (annual, 2022-12-31) — Provisionand Write Offof Assets: 6399000.00
GMED cash_flow (annual, 2022-12-31) — Purchase Of Business: -31435000.00
GMED cash_flow (annual, 2022-12-31) — Purchase Of Investment: -419534000.00
GMED cash_flow (annual, 2022-12-31) — Purchase Of PPE: -74047000.00
GMED balance_sheet (annual, 2022-12-31) — Raw Materials: 60324000.00
GMED balance_sheet (annual, 2022-12-31) — Receivables: 217308000.00
GMED income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 213208000.00
GMED income_statement (annual, 2022-12-31) — Reconciled Depreciation: 68252000.00
GMED cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -144493000.00
GMED income_statement (annual, 2022-12-31) — Research And Development: 73015000.00
GMED income_statement (annual, 2022-12-31) — Restructuring And Mergern Acquisition: 5959000.00
GMED balance_sheet (annual, 2022-12-31) — Retained Earnings: 1239951000.00
GMED cash_flow (annual, 2022-12-31) — Sale Of Investment: 414654000.00
GMED income_statement (annual, 2022-12-31) — Selling General And Administration: 432117000.00
GMED balance_sheet (annual, 2022-12-31) — Share Issued: 100192379.00
GMED income_statement (annual, 2022-12-31) — Special Income Charges: -8300000.00
GMED cash_flow (annual, 2022-12-31) — Stock Based Compensation: 32810000.00
GMED balance_sheet (annual, 2022-12-31) — Stockholders Equity: 1846373000.00
GMED balance_sheet (annual, 2022-12-31) — Tangible Book Value: 1585328000.00
GMED income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: -2022440.00
GMED income_statement (annual, 2022-12-31) — Tax Provision: 52850000.00
GMED income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.22
GMED balance_sheet (annual, 2022-12-31) — Taxes Receivable: 4061000.00
GMED balance_sheet (annual, 2022-12-31) — Total Assets: 2076126000.00
GMED balance_sheet (annual, 2022-12-31) — Total Capitalization: 1846373000.00
GMED balance_sheet (annual, 2022-12-31) — Total Debt: 6011000.00
GMED balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 1846373000.00
GMED income_statement (annual, 2022-12-31) — Total Expenses: 786592000.00
GMED balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 229753000.00
GMED balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 1092782000.00
GMED balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 70549000.00
GMED income_statement (annual, 2022-12-31) — Total Operating Income As Reported: 227951000.00
GMED income_statement (annual, 2022-12-31) — Total Other Finance Cost: -14233000.00
GMED balance_sheet (annual, 2022-12-31) — Total Tax Payable: 11019000.00
GMED income_statement (annual, 2022-12-31) — Total Unusual Items: -9320000.00
GMED income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: -9320000.00
GMED balance_sheet (annual, 2022-12-31) — Work In Process: 18699000.00
GMED balance_sheet (annual, 2022-12-31) — Working Capital: 824140000.00
GMED income_statement (annual, 2023-12-31) — +Operating Expense: 818886000.00
GMED income_statement (annual, 2023-12-31) — +Total Revenue: 1568476000.00
GMED balance_sheet (annual, 2023-12-31) — Accounts Payable: 56671000.00
GMED balance_sheet (annual, 2023-12-31) — Accounts Receivable: 503235000.00
GMED balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -425695000.00
GMED balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 2870749000.00
GMED balance_sheet (annual, 2023-12-31) — Allowance For Doubtful Accounts Receivable: -8934000.00
GMED income_statement (annual, 2023-12-31) — Amortization: 51032000.00
GMED income_statement (annual, 2023-12-31) — Amortization Of Intangibles Income Statement: 51032000.00
GMED cash_flow (annual, 2023-12-31) — Amortization Of Securities: 793000.00
GMED income_statement (annual, 2023-12-31) — Basic Average Shares: 113087000.00
GMED income_statement (annual, 2023-12-31) — Basic EPS: 1.09
GMED cash_flow (annual, 2023-12-31) — Beginning Cash Position: 150466000.00
GMED balance_sheet (annual, 2023-12-31) — Buildings And Improvements: 102449000.00
GMED cash_flow (annual, 2023-12-31) — Capital Expenditure: -78274000.00
GMED balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 103004000.00
GMED balance_sheet (annual, 2023-12-31) — Capital Stock: 136000.00
GMED balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 467292000.00
GMED balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 517789000.00
GMED cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: -231821000.00
GMED cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: 302968000.00
GMED cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: 243499000.00
GMED cash_flow (annual, 2023-12-31) — Change In Account Payable: -14223000.00
GMED cash_flow (annual, 2023-12-31) — Change In Accrued Expense: 17127000.00
GMED cash_flow (annual, 2023-12-31) — Change In Inventory: -70328000.00
GMED cash_flow (annual, 2023-12-31) — Change In Other Working Capital: -408000.00
GMED cash_flow (annual, 2023-12-31) — Change In Payable: -14223000.00
GMED cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: 2904000.00
GMED cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: 1148000.00
GMED cash_flow (annual, 2023-12-31) — Change In Receivables: -49914000.00
GMED cash_flow (annual, 2023-12-31) — Change In Working Capital: -116598000.00
GMED cash_flow (annual, 2023-12-31) — Changes In Account Receivables: -49914000.00
GMED cash_flow (annual, 2023-12-31) — Changes In Cash: 314646000.00
GMED balance_sheet (annual, 2023-12-31) — Common Stock: 136000.00
GMED balance_sheet (annual, 2023-12-31) — Common Stock Equity: 3997959000.00
GMED cash_flow (annual, 2023-12-31) — Common Stock Payments: -225562000.00
GMED income_statement (annual, 2023-12-31) — Cost Of Revenue: 548174000.00
GMED balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 75917000.00
GMED balance_sheet (annual, 2023-12-31) — Current Assets: 1915374000.00
GMED balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 11967000.00
GMED balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 11967000.00
GMED balance_sheet (annual, 2023-12-31) — Current Deferred Liabilities: 18369000.00
GMED balance_sheet (annual, 2023-12-31) — Current Deferred Revenue: 18369000.00
GMED balance_sheet (annual, 2023-12-31) — Current Liabilities: 392347000.00
GMED cash_flow (annual, 2023-12-31) — Deferred Income Tax: -57789000.00
GMED cash_flow (annual, 2023-12-31) — Deferred Tax: -57789000.00
GMED cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 145526000.00
GMED income_statement (annual, 2023-12-31) — Depreciation Amortization Depletion Income Statement: 51032000.00
GMED cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 145526000.00
GMED income_statement (annual, 2023-12-31) — Depreciation And Amortization In Income Statement: 51032000.00
GMED income_statement (annual, 2023-12-31) — Diluted Average Shares: 114630000.00
GMED income_statement (annual, 2023-12-31) — Diluted EPS: 1.07
GMED income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 122873000.00
GMED income_statement (annual, 2023-12-31) — EBIT: 201416000.00
GMED income_statement (annual, 2023-12-31) — EBITDA: 346942000.00
GMED cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: 2180000.00
GMED cash_flow (annual, 2023-12-31) — End Cash Position: 467292000.00
GMED cash_flow (annual, 2023-12-31) — Financing Cash Flow: -231821000.00
GMED balance_sheet (annual, 2023-12-31) — Finished Goods: 707465000.00
GMED cash_flow (annual, 2023-12-31) — Free Cash Flow: 165225000.00
GMED income_statement (annual, 2023-12-31) — Gain On Sale Of Security: 14259000.00
GMED balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: -10192000.00
GMED balance_sheet (annual, 2023-12-31) — Goodwill: 1434540000.00
GMED balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 2359143000.00
GMED balance_sheet (annual, 2023-12-31) — Gross Accounts Receivable: 512169000.00
GMED balance_sheet (annual, 2023-12-31) — Gross PPE: 1072558000.00
GMED income_statement (annual, 2023-12-31) — Gross Profit: 1020302000.00
GMED cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 100593000.00
GMED balance_sheet (annual, 2023-12-31) — Income Tax Payable: 3845000.00
GMED balance_sheet (annual, 2023-12-31) — Inventory: 848135000.00
GMED balance_sheet (annual, 2023-12-31) — Invested Capital: 4415359000.00
GMED cash_flow (annual, 2023-12-31) — Investing Cash Flow: 302968000.00
GMED balance_sheet (annual, 2023-12-31) — Investmentin Financial Assets: 75428000.00
GMED balance_sheet (annual, 2023-12-31) — Investments And Advances: 75428000.00
GMED balance_sheet (annual, 2023-12-31) — Land And Improvements: 9748000.00
GMED balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 91037000.00
GMED balance_sheet (annual, 2023-12-31) — Long Term Debt: 417400000.00
GMED balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 508437000.00
GMED cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: -296028000.00
GMED cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: -225562000.00
GMED cash_flow (annual, 2023-12-31) — Net Foreign Currency Exchange Gain Loss: -13674000.00
GMED income_statement (annual, 2023-12-31) — Net Income: 122873000.00
GMED income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 122873000.00
GMED income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 122873000.00
GMED income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 122873000.00
GMED income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 122873000.00
GMED cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 122873000.00
GMED income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 122873000.00
GMED cash_flow (annual, 2023-12-31) — Net Intangibles Purchase And Sale: 0.00
GMED income_statement (annual, 2023-12-31) — Net Interest Income: 20130000.00
GMED cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: 677270000.00
GMED cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: 0.00
GMED income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: 20130000.00
GMED cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -18656000.00
GMED balance_sheet (annual, 2023-12-31) — Net PPE: 646863000.00
GMED cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -78274000.00
GMED cash_flow (annual, 2023-12-31) — Net Short Term Debt Issuance: 0.00
GMED balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 1638816000.00
GMED balance_sheet (annual, 2023-12-31) — Non Current Deferred Assets: 10685000.00
GMED balance_sheet (annual, 2023-12-31) — Non Current Deferred Liabilities: 84421000.00
GMED balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Assets: 10685000.00
GMED balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Liabilities: 84421000.00
GMED income_statement (annual, 2023-12-31) — Normalized EBITDA: 400957000.00
GMED income_statement (annual, 2023-12-31) — Normalized Income: 163001573.13
GMED cash_flow (annual, 2023-12-31) — Operating Cash Flow: 243499000.00
GMED cash_flow (annual, 2023-12-31) — Operating Gains Losses: -12133000.00
GMED income_statement (annual, 2023-12-31) — Operating Income: 201416000.00
GMED income_statement (annual, 2023-12-31) — Operating Revenue: 1568476000.00
GMED balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 136335662.00
GMED balance_sheet (annual, 2023-12-31) — Other Current Assets: 44580000.00
GMED balance_sheet (annual, 2023-12-31) — Other Current Liabilities: 61035000.00
GMED balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: -10192000.00
GMED income_statement (annual, 2023-12-31) — Other Income Expense: -56153000.00
GMED balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 924603000.00
GMED cash_flow (annual, 2023-12-31) — Other Non Cash Items: 94261000.00
GMED balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 78590000.00
GMED balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 102919000.00
GMED income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: -2138000.00
GMED balance_sheet (annual, 2023-12-31) — Other Properties: 960361000.00
GMED balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 50497000.00
GMED income_statement (annual, 2023-12-31) — Other Special Charges: 434000.00
GMED balance_sheet (annual, 2023-12-31) — Payables: 84242000.00
GMED balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 160159000.00
GMED balance_sheet (annual, 2023-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 140817000.00
GMED income_statement (annual, 2023-12-31) — Pretax Income: 165393000.00
GMED cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 12397000.00
GMED balance_sheet (annual, 2023-12-31) — Properties: 0.00
GMED cash_flow (annual, 2023-12-31) — Provisionand Write Offof Assets: 14617000.00
GMED cash_flow (annual, 2023-12-31) — Purchase Of Business: -296028000.00
GMED cash_flow (annual, 2023-12-31) — Purchase Of Intangibles: 0.00
GMED cash_flow (annual, 2023-12-31) — Purchase Of Investment: -100643000.00
GMED cash_flow (annual, 2023-12-31) — Purchase Of PPE: -78274000.00
GMED balance_sheet (annual, 2023-12-31) — Raw Materials: 103349000.00
GMED balance_sheet (annual, 2023-12-31) — Receivables: 504870000.00
GMED income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 453680000.00
GMED income_statement (annual, 2023-12-31) — Reconciled Depreciation: 145526000.00
GMED cash_flow (annual, 2023-12-31) — Repayment Of Debt: 0.00
GMED cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: -225562000.00
GMED income_statement (annual, 2023-12-31) — Research And Development: 124010000.00
GMED income_statement (annual, 2023-12-31) — Restructuring And Mergern Acquisition: 68274000.00
GMED balance_sheet (annual, 2023-12-31) — Retained Earnings: 1137266000.00
GMED cash_flow (annual, 2023-12-31) — Sale Of Investment: 777913000.00
GMED income_statement (annual, 2023-12-31) — Selling General And Administration: 643844000.00
GMED balance_sheet (annual, 2023-12-31) — Share Issued: 136335662.00
GMED cash_flow (annual, 2023-12-31) — Short Term Debt Payments: 0.00
GMED income_statement (annual, 2023-12-31) — Special Income Charges: -68274000.00
GMED cash_flow (annual, 2023-12-31) — Stock Based Compensation: 52742000.00
GMED balance_sheet (annual, 2023-12-31) — Stockholders Equity: 3997959000.00
GMED balance_sheet (annual, 2023-12-31) — Tangible Book Value: 1638816000.00
GMED income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: -13886426.87
GMED income_statement (annual, 2023-12-31) — Tax Provision: 42520000.00
GMED income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.26
GMED balance_sheet (annual, 2023-12-31) — Taxes Receivable: 1635000.00
GMED balance_sheet (annual, 2023-12-31) — Total Assets: 5086083000.00
GMED balance_sheet (annual, 2023-12-31) — Total Capitalization: 4415359000.00
GMED balance_sheet (annual, 2023-12-31) — Total Debt: 520404000.00
GMED balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 3997959000.00
GMED income_statement (annual, 2023-12-31) — Total Expenses: 1367060000.00
GMED balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 1088124000.00
GMED balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 3170709000.00
GMED balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 695777000.00
GMED income_statement (annual, 2023-12-31) — Total Operating Income As Reported: 133142000.00
GMED income_statement (annual, 2023-12-31) — Total Other Finance Cost: -20130000.00
GMED balance_sheet (annual, 2023-12-31) — Total Tax Payable: 27571000.00
GMED income_statement (annual, 2023-12-31) — Total Unusual Items: -54015000.00
GMED income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: -54015000.00
GMED balance_sheet (annual, 2023-12-31) — Work In Process: 37321000.00
GMED balance_sheet (annual, 2023-12-31) — Working Capital: 1523027000.00
GMED cash_flow (quarterly, 2024-09-30) — Amortization Cash Flow: 30076000.00
GMED cash_flow (quarterly, 2024-09-30) — Amortization Of Intangibles: 30076000.00
GMED cash_flow (quarterly, 2024-09-30) — Amortization Of Securities: -105000.00
GMED balance_sheet (quarterly, 2024-09-30) — Available For Sale Securities: 10548000.00
GMED balance_sheet (quarterly, 2024-09-30) — Current Debt: 437142000.00
GMED cash_flow (quarterly, 2024-09-30) — Depreciation: 36871000.00
GMED balance_sheet (quarterly, 2024-09-30) — Held To Maturity Securities: 1749000.00
GMED balance_sheet (quarterly, 2024-09-30) — Other Current Borrowings: 437142000.00
GMED income_statement (quarterly, 2024-09-30) — Other Special Charges: -676000.00
GMED income_statement (annual, 2024-12-31) — +Operating Expense: 1264489000.00
GMED income_statement (annual, 2024-12-31) — +Total Revenue: 2519355000.00
GMED balance_sheet (annual, 2024-12-31) — Accounts Payable: 75118000.00
GMED balance_sheet (annual, 2024-12-31) — Accounts Receivable: 557697000.00
GMED balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -545786000.00
GMED balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 3031244000.00
GMED balance_sheet (annual, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -15505000.00
GMED income_statement (annual, 2024-12-31) — Amortization: 119373000.00
GMED income_statement (annual, 2024-12-31) — Amortization Of Intangibles Income Statement: 119373000.00
GMED cash_flow (annual, 2024-12-31) — Amortization Of Securities: -635000.00
GMED cash_flow (quarterly, 2024-12-31) — Amortization Of Securities: -516000.00
GMED income_statement (annual, 2024-12-31) — Basic Average Shares: 135726000.00
GMED income_statement (annual, 2024-12-31) — Basic EPS: 0.76
GMED cash_flow (annual, 2024-12-31) — Beginning Cash Position: 467292000.00
GMED balance_sheet (annual, 2024-12-31) — Buildings And Improvements: 100128000.00
GMED cash_flow (annual, 2024-12-31) — Capital Expenditure: -115429000.00
GMED balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 93837000.00
GMED balance_sheet (annual, 2024-12-31) — Capital Stock: 137000.00
GMED balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 784438000.00
GMED balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 890057000.00
GMED cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: -27696000.00
GMED cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -176051000.00
GMED cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: 520638000.00
GMED cash_flow (annual, 2024-12-31) — Change In Account Payable: 17663000.00
GMED cash_flow (annual, 2024-12-31) — Change In Accrued Expense: 5023000.00
GMED cash_flow (annual, 2024-12-31) — Change In Inventory: -29860000.00
GMED cash_flow (annual, 2024-12-31) — Change In Other Working Capital: -13377000.00
GMED cash_flow (annual, 2024-12-31) — Change In Payable: 17663000.00
GMED cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: 22686000.00
GMED cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: 1059000.00
GMED cash_flow (annual, 2024-12-31) — Change In Receivables: -78062000.00
GMED cash_flow (annual, 2024-12-31) — Change In Working Capital: -97554000.00
GMED cash_flow (annual, 2024-12-31) — Changes In Account Receivables: -78062000.00
GMED cash_flow (annual, 2024-12-31) — Changes In Cash: 316891000.00
GMED balance_sheet (annual, 2024-12-31) — Common Stock: 137000.00
GMED balance_sheet (annual, 2024-12-31) — Common Stock Equity: 4177333000.00
GMED cash_flow (annual, 2024-12-31) — Common Stock Payments: -85787000.00
GMED income_statement (annual, 2024-12-31) — Cost Of Revenue: 1035479000.00
GMED balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 74684000.00
GMED balance_sheet (annual, 2024-12-31) — Current Assets: 2177260000.00
GMED balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 10249000.00
GMED balance_sheet (annual, 2024-12-31) — Current Debt: 443351000.00
GMED balance_sheet (quarterly, 2024-12-31) — Current Debt: 443351000.00
GMED balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 453600000.00
GMED balance_sheet (annual, 2024-12-31) — Current Deferred Liabilities: 22140000.00
GMED balance_sheet (annual, 2024-12-31) — Current Deferred Revenue: 22140000.00
GMED balance_sheet (annual, 2024-12-31) — Current Liabilities: 855913000.00
GMED cash_flow (annual, 2024-12-31) — Deferred Income Tax: -125902000.00
GMED cash_flow (annual, 2024-12-31) — Deferred Tax: -125902000.00
GMED cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 253389000.00
GMED income_statement (annual, 2024-12-31) — Depreciation Amortization Depletion Income Statement: 119373000.00
GMED cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 253389000.00
GMED income_statement (annual, 2024-12-31) — Depreciation And Amortization In Income Statement: 119373000.00
GMED income_statement (annual, 2024-12-31) — Diluted Average Shares: 137863000.00
GMED income_statement (annual, 2024-12-31) — Diluted EPS: 0.75
GMED income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: 102984000.00
GMED income_statement (annual, 2024-12-31) — EBIT: 219387000.00
GMED income_statement (annual, 2024-12-31) — EBITDA: 472776000.00
GMED cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: 255000.00
GMED cash_flow (annual, 2024-12-31) — End Cash Position: 784438000.00
GMED cash_flow (annual, 2024-12-31) — Financing Cash Flow: -27696000.00
GMED balance_sheet (annual, 2024-12-31) — Finished Goods: 491474000.00
GMED cash_flow (annual, 2024-12-31) — Free Cash Flow: 405209000.00
GMED income_statement (annual, 2024-12-31) — Gain On Sale Of Security: -43285000.00
GMED balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: -6861000.00
GMED balance_sheet (annual, 2024-12-31) — Goodwill: 1432387000.00
GMED balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 2227504000.00
GMED balance_sheet (annual, 2024-12-31) — Gross Accounts Receivable: 573202000.00
GMED balance_sheet (annual, 2024-12-31) — Gross PPE: 1157342000.00
GMED income_statement (annual, 2024-12-31) — Gross Profit: 1483876000.00
GMED cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 158508000.00
GMED balance_sheet (annual, 2024-12-31) — Income Tax Payable: 10725000.00
GMED balance_sheet (annual, 2024-12-31) — Inventory: 659233000.00
GMED balance_sheet (annual, 2024-12-31) — Invested Capital: 4620684000.00
GMED cash_flow (annual, 2024-12-31) — Investing Cash Flow: -176051000.00
GMED balance_sheet (annual, 2024-12-31) — Investmentin Financial Assets: 66134000.00
GMED balance_sheet (annual, 2024-12-31) — Investments And Advances: 66134000.00
GMED balance_sheet (annual, 2024-12-31) — Land And Improvements: 9731000.00
GMED balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 83588000.00
GMED balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 83588000.00
GMED cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: -17635000.00
GMED cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: -85787000.00
GMED cash_flow (annual, 2024-12-31) — Net Foreign Currency Exchange Gain Loss: 25212000.00
GMED income_statement (annual, 2024-12-31) — Net Income: 102984000.00
GMED income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 102984000.00
GMED income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 102984000.00
GMED income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 102984000.00
GMED income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 102984000.00
GMED cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 102984000.00
GMED income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 102984000.00
GMED cash_flow (annual, 2024-12-31) — Net Intangibles Purchase And Sale: 0.00
GMED income_statement (annual, 2024-12-31) — Net Interest Income: -4189000.00
GMED cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: -42987000.00
GMED cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: 0.00
GMED income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -4189000.00
GMED cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -52348000.00
GMED balance_sheet (annual, 2024-12-31) — Net PPE: 611556000.00
GMED cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -115429000.00
GMED cash_flow (annual, 2024-12-31) — Net Short Term Debt Issuance: 0.00
GMED balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 1949829000.00
GMED balance_sheet (annual, 2024-12-31) — Non Current Deferred Assets: 94200000.00
GMED balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 23889000.00
GMED balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Assets: 94200000.00
GMED balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Liabilities: 23889000.00
GMED income_statement (annual, 2024-12-31) — Normalized EBITDA: 569457000.00
GMED income_statement (annual, 2024-12-31) — Normalized Income: 185452893.00
GMED cash_flow (annual, 2024-12-31) — Operating Cash Flow: 520638000.00
GMED cash_flow (annual, 2024-12-31) — Operating Gains Losses: 30764000.00
GMED income_statement (annual, 2024-12-31) — Operating Income: 219387000.00
GMED income_statement (annual, 2024-12-31) — Operating Revenue: 2519355000.00
GMED balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 137420316.00
GMED balance_sheet (annual, 2024-12-31) — Other Current Assets: 49640000.00
GMED balance_sheet (annual, 2024-12-31) — Other Current Borrowings: 443351000.00
GMED balance_sheet (quarterly, 2024-12-31) — Other Current Borrowings: 443351000.00
GMED balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 33739000.00
GMED balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: -6861000.00
GMED income_statement (annual, 2024-12-31) — Other Income Expense: -94476000.00
GMED balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 795117000.00
GMED cash_flow (annual, 2024-12-31) — Other Non Cash Items: 262421000.00
GMED balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 75096000.00
GMED balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 111027000.00
GMED income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: 2205000.00
GMED balance_sheet (annual, 2024-12-31) — Other Properties: 1047483000.00
GMED balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 105619000.00
GMED income_statement (annual, 2024-12-31) — Other Special Charges: 314000.00
GMED income_statement (quarterly, 2024-12-31) — Other Special Charges: -314000.00
GMED balance_sheet (annual, 2024-12-31) — Payables: 119931000.00
GMED balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 194615000.00
GMED balance_sheet (annual, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 151819000.00
GMED income_statement (annual, 2024-12-31) — Pretax Income: 120722000.00
GMED cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 110439000.00
GMED balance_sheet (annual, 2024-12-31) — Properties: 0.00
GMED cash_flow (annual, 2024-12-31) — Provisionand Write Offof Assets: 40345000.00
GMED cash_flow (annual, 2024-12-31) — Purchase Of Business: -17635000.00
GMED cash_flow (annual, 2024-12-31) — Purchase Of Intangibles: 0.00
GMED cash_flow (annual, 2024-12-31) — Purchase Of Investment: -113504000.00
GMED cash_flow (annual, 2024-12-31) — Purchase Of PPE: -115429000.00
GMED balance_sheet (annual, 2024-12-31) — Raw Materials: 121984000.00
GMED balance_sheet (annual, 2024-12-31) — Receivables: 578330000.00
GMED income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 901463000.00
GMED income_statement (annual, 2024-12-31) — Reconciled Depreciation: 253389000.00
GMED cash_flow (annual, 2024-12-31) — Repayment Of Debt: 0.00
GMED cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: -85787000.00
GMED income_statement (annual, 2024-12-31) — Research And Development: 163754000.00
GMED income_statement (annual, 2024-12-31) — Restructuring And Mergern Acquisition: 53396000.00
GMED balance_sheet (annual, 2024-12-31) — Retained Earnings: 1152813000.00
GMED cash_flow (annual, 2024-12-31) — Sale Of Investment: 70517000.00
GMED income_statement (annual, 2024-12-31) — Selling General And Administration: 981362000.00
GMED balance_sheet (annual, 2024-12-31) — Share Issued: 137420316.00
GMED cash_flow (annual, 2024-12-31) — Short Term Debt Payments: 0.00
GMED income_statement (annual, 2024-12-31) — Special Income Charges: -53396000.00
GMED cash_flow (annual, 2024-12-31) — Stock Based Compensation: 54191000.00
GMED balance_sheet (annual, 2024-12-31) — Stockholders Equity: 4177333000.00